Artificial Cells, Nanomedicine, and Biotechnology最新文献

筛选
英文 中文
Statement of Retraction 撤回声明
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-12-31 DOI: 10.1080/21691401.2022.2054515
Sen Wei, Jinghao Liu, Xin Li, Xing Liu
{"title":"Statement of Retraction","authors":"Sen Wei, Jinghao Liu, Xin Li, Xing Liu","doi":"10.1080/21691401.2022.2054515","DOIUrl":"https://doi.org/10.1080/21691401.2022.2054515","url":null,"abstract":"","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"31 1","pages":"81 - 81"},"PeriodicalIF":5.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73943165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative stress and histopathological changes in several organs of mice injected with biogenic silver nanoparticles. 生物源性纳米银注射小鼠多个器官的氧化应激和组织病理学改变。
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-12-01 DOI: 10.1080/21691401.2022.2149931
Shushanik Kazaryan, Lilit Farsiyan, Juleta Tumoyan, Gayane Kirakosyan, Naira Ayvazyan, Hrachik Gasparyan, Sona Buloyan, Lilit Arshakyan, Ara Kirakosyan, Ashkhen Hovhannisyan
{"title":"Oxidative stress and histopathological changes in several organs of mice injected with biogenic silver nanoparticles.","authors":"Shushanik Kazaryan,&nbsp;Lilit Farsiyan,&nbsp;Juleta Tumoyan,&nbsp;Gayane Kirakosyan,&nbsp;Naira Ayvazyan,&nbsp;Hrachik Gasparyan,&nbsp;Sona Buloyan,&nbsp;Lilit Arshakyan,&nbsp;Ara Kirakosyan,&nbsp;Ashkhen Hovhannisyan","doi":"10.1080/21691401.2022.2149931","DOIUrl":"https://doi.org/10.1080/21691401.2022.2149931","url":null,"abstract":"<p><p>The widespread use of silver nanoparticles (AgNPs) requires a study of their safety. The aim of the present study was to assess the levels of oxidative stress markers and histopathological changes in the experimental model of sarcoma S-180 of outbred mice caused by biogenic AgNPs. AgNPs were synthesized using 50% ethanol extract of <i>Ocimum araratum</i> leaves that was standardized for rosmarinic acid content. The effects of AgNPs were tested on chemiluminescence (ChL), malonic dialdehyde (MDA) content and activity of superoxide dismutase (SOD) in healthy and experimental model of sarcoma S-180 mice. It was shown that, under the influence of AgNPs, the intensity of ChL decreased, in contrast with control groups (with the exception of the hepatocytes of animals with transplanted sarcoma). The presence of AgNPs leads to the decrease of MDA in the tissues of healthy mice and to a slight increase of MDA content in the tumour and kidney tissues. AgNPs neutralize the activity of SOD in kidney tissue samples in animals with transplanted sarcoma, and in tumour tissue, they reduce SOD activity by three times. The results of the histological analysis indicate that AgNPs not only cause the destruction of tumour tissue but also lead to structural changes in hepatocytes and nephrons, which can affect the function of these organs. AgNPs are potential agents for antitumor therapy. Future studies are needed using biocompatible non-toxic NPs that meet the requirement for these drugs.</p>","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"50 1","pages":"331-342"},"PeriodicalIF":5.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10343413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Potential applications of PEGylated green gold nanoparticles in cyclophosphamide-induced cystitis 聚乙二醇化绿金纳米颗粒在环磷酰胺性膀胱炎中的潜在应用
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-12-01 DOI: 10.1080/21691401.2022.2078340
Bushra Shal, Safa Amanat, A. Khan, You Jeong Lee, H. Ali, F. Din, Youmie Park, Salman Khan
{"title":"Potential applications of PEGylated green gold nanoparticles in cyclophosphamide-induced cystitis","authors":"Bushra Shal, Safa Amanat, A. Khan, You Jeong Lee, H. Ali, F. Din, Youmie Park, Salman Khan","doi":"10.1080/21691401.2022.2078340","DOIUrl":"https://doi.org/10.1080/21691401.2022.2078340","url":null,"abstract":"Abstract We investigated the effect of green tea extract PEGylated gold nanoparticles (P-AuNPs) making use of its targeted and sustained drug delivery against cyclophosphamide (CYP)-induced cystitis. AuNPs were synthesized by reduction reaction of gold salts with green tea extract following the concept of green synthesis. Mostly spherical-shaped P-AuNPs were synthesized with an average size of 14.3 ± 3.3 nm. Pre-treatment with P-AuNPs (1, 10 mg/kg, i.p.) before CYP (150 mg/kg, i.p.) challenge suggested its uroprotective properties. P-AuNPs significantly reversed all pain-like behaviours and toxicities produced by CYP resulting in a decreased aspartate aminotransferase, alanine aminotransferase, C-reactive protein, and creatinine level. P-AuNPs increased anti-oxidant system by increasing the level of reduced glutathione, glutathione-S-transferase, catalase and superoxide dismutase, and reduced nitric oxide production in bladder tissue. Additionally, it attenuated hypokalaemia and hyponatremia, along with a decrease in Evans blue content in bladder tissue and peritoneal cavity. CYP-induced bladder tissue damage observed by macroscopic and histological findings were remarkably attenuated by P-AuNPs, along with reduced fibrosis of collagen fibre in bladder smooth muscles shown by Masson’s trichrome staining. Additionally, alterations in hematological parameters and clinical scoring were also prevented by P-AuNPs suggesting its uroprotective effect.","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"59 1","pages":"130 - 146"},"PeriodicalIF":5.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76307555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Antibacterial, antioxidant, and haemolytic potential of silver nanoparticles biosynthesized using roots extract of Cannabis sativa plant. 用大麻根提取物生物合成纳米银的抗菌、抗氧化和溶血潜能。
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-12-01 DOI: 10.1080/21691401.2022.2149543
Suman Suman, Lacy Loveleen, Meena Bhandari, Asad Syed, Ali H Bahkali, Romila Manchanda, Surendra Nimesh
{"title":"Antibacterial, antioxidant, and haemolytic potential of silver nanoparticles biosynthesized using roots extract of <i>Cannabis sativa</i> plant.","authors":"Suman Suman,&nbsp;Lacy Loveleen,&nbsp;Meena Bhandari,&nbsp;Asad Syed,&nbsp;Ali H Bahkali,&nbsp;Romila Manchanda,&nbsp;Surendra Nimesh","doi":"10.1080/21691401.2022.2149543","DOIUrl":"https://doi.org/10.1080/21691401.2022.2149543","url":null,"abstract":"<p><p>In this study, <i>Cannabis sativa</i> roots extract has been employed for the biosynthesis of silver nanoparticles (AgNPs). The appearance of reddish-brown colour followed by absorption peak of AgNPs at 408 nm through UV-vis spectrophotometry suggested biosynthesis of AgNPs. The size of the particles ranged from 90-113 nm, confirmed using DLS and TEM along with zeta potential of -25.3 mV. The FTIR provided information regarding the phytochemical capping. The study was further elaborated for determining AgNPs antibacterial, antioxidant, and cellular toxicity using MIC, DPPH, MTT, and haemolytic assays, respectively. The AgNPs were significantly effective against <i>Staphylococcus aureus</i> (Gram-positive), as compared to that of <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i>, and <i>Escherichia coli</i> (Gram-negative). AgNPs also exhibited remarkable antioxidant potential wherein 58.01 ± 0.09% free radical scavenging was observed at a concentration of 100 µg/ml. AgNPs revealed lower cytotoxicity where cell viability was observed to be 52.38 ± 0.6% at a very high concentration of 500 µg/ml in HEK 293 cells. Further, very low toxicity was seen in RBCs i.e. 6.47 ± 0.04% at a high concentration of 200 µg/ml. Thus, the current study beholds anticipation that <i>Cannabis sativa</i> ethanolic root extract-mediated AgNPs may play a vital role in therapeutic.</p>","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"50 1","pages":"343-351"},"PeriodicalIF":5.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10356772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis. 临床试验中PD-1/PD-L1抑制剂联合CTLA-4抑制剂治疗相关不良事件:一项荟萃分析
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-12-01 DOI: 10.1080/21691401.2022.2131354
Ze Mi, Yunshu Zhang, Zhichao Feng, Jiahao Liu, Jianmin Wu, Hongpei Tan, Xiaoqian Ma, Zhenguo Liu, Pengfei Rong
{"title":"Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis.","authors":"Ze Mi,&nbsp;Yunshu Zhang,&nbsp;Zhichao Feng,&nbsp;Jiahao Liu,&nbsp;Jianmin Wu,&nbsp;Hongpei Tan,&nbsp;Xiaoqian Ma,&nbsp;Zhenguo Liu,&nbsp;Pengfei Rong","doi":"10.1080/21691401.2022.2131354","DOIUrl":"https://doi.org/10.1080/21691401.2022.2131354","url":null,"abstract":"<p><strong>Aim: </strong>PD-1/PD-L1 inhibitors in combination with CTLA-4 inhibitors are being tested in a number of ongoing clinical trials. As a result, it is critical to fully comprehend the toxicity characteristics of adverse events in combination therapy. This study aims to extensively compare the incidences and ORs of treatment-related adverse events between two combination strategies.</p><p><strong>Methods: </strong>The eligible articles were searched from PubMed, EMBASE and Cochrane databases for studies published between 1 January 2010 and 1 May 2021, investigating PD-1/PD-L1 inhibitors plus CTLA-4 inhibitor-based combined clinical therapies. The mean incidences and pooled ORs of all-grade and grade 3 or higher adverse events were calculated by random-effects model using <i>Stata 12.1</i>. Heterogeneity between studies was assessed with I<sup>2</sup> statistics and Chi square-based Q statistic. The overall risk of bias was assessed by <i>Review Manager 5.3</i>.</p><p><strong>Results: </strong>A total of 26 eligible studies of 3607 patients were selected; 2852 patients developed at least one all-grade adverse event. PD-L1 inhibitors plus CTLA-4 inhibitors regimen (incidence 0.67, 95% CI: 0.57-0.77) had marked advantage over PD-1 inhibitors plus CTLA-4 inhibitors regimen (incidence 0.89, 95% CI: 0.86-0.93).</p><p><strong>Conclusion: </strong>PD-L1 inhibitors plus CTLA-4 inhibitors shows better safety in treatment-related adverse events than PD-1 inhibitors plus CTLA-4 inhibitors.</p>","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"50 1","pages":"301-309"},"PeriodicalIF":5.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10446303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles DPPC多层囊泡对囊胚细胞膜脂质分布的调节
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-06-17 DOI: 10.1080/21691401.2022.2088545
Hugo de Rossi, Camila Bortoliero Costa, Luana Teixeira Rodrigues-Rossi, Giovana Barros Nunes, D. Spinosa Chéles, Isabella Maran Pereira, D. F. O. Rocha, E. Feitosa, Ana Valéria Colnaghi Simionato, Gisele Zoccal Mingoti, Pedro Henrique Benites Aoki, M. F. Gouveia Nogueira
{"title":"Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles","authors":"Hugo de Rossi, Camila Bortoliero Costa, Luana Teixeira Rodrigues-Rossi, Giovana Barros Nunes, D. Spinosa Chéles, Isabella Maran Pereira, D. F. O. Rocha, E. Feitosa, Ana Valéria Colnaghi Simionato, Gisele Zoccal Mingoti, Pedro Henrique Benites Aoki, M. F. Gouveia Nogueira","doi":"10.1080/21691401.2022.2088545","DOIUrl":"https://doi.org/10.1080/21691401.2022.2088545","url":null,"abstract":"Abstract The aim of this study was to evaluate the effect of multilamellar vesicles (MLVs) of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in co-culture with in vitro-produced bovine embryos (IVPEs). The stability of five concentrations of MLVs (1.0, 1.25, 1.5, 1.75, and 2.0 mM) produced using ultrapure water or embryonic culture medium with 24 or 48 h of incubation at 38.5 °C with 5% CO2 was assessed. In addition, the toxicity of MLVs and their modulation of the lipid profile of the plasma membrane of IVPEs were evaluated after 48 h of co-culture. Both media allowed the production of MLVs. Incubation (24 and 48 h) did not impair the MLV structure but affected the average diameter. The rate of blastocyst production was not reduced, demonstrating the nontoxicity of the MLVs even at 2.0 mmol/L. The lipid profile of the embryos was different depending on the MLV concentration. In comparison with control embryos, embryos cultured with MLVs at 2.0 mmol/L had a higher relative abundance of six lipid ions (m/z 720.6, 754.9, 759.0, 779.1, 781.2, and 797.3). This study sheds light on a new culture system in which the MLV concentration could change the lipid profile of the embryonic cell membrane in a dose-dependent manner.","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"69 1","pages":"158 - 167"},"PeriodicalIF":5.8,"publicationDate":"2022-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85549725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Surface-modified vacuole-based daunorubicin delivery system for acute myeloid leukaemia (AML) and their selective therapeutics 表面修饰的基于液泡的柔红霉素给药系统治疗急性髓性白血病及其选择性治疗
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-05-30 DOI: 10.1080/21691401.2022.2078339
Wooil Choi, Yang-Hoon Kim, Jiho Min
{"title":"Surface-modified vacuole-based daunorubicin delivery system for acute myeloid leukaemia (AML) and their selective therapeutics","authors":"Wooil Choi, Yang-Hoon Kim, Jiho Min","doi":"10.1080/21691401.2022.2078339","DOIUrl":"https://doi.org/10.1080/21691401.2022.2078339","url":null,"abstract":"Abstract The vacuoles in Saccharomyces cerevisiae are the key players digesting the waste within the cell. This functional organelle corresponding to the lysosome of mammalians contains acidic hydrolases and specific membrane proteins. Vacuoles have more than 60 hydrolytic enzymes and can easily be modified by genetic engineering. In previous study, we optimised the encapsulation condition with appropriate time and concentration and confirmed the use of vacuole as drug delivery carrier for acute myeloid leukaemia treatment. In this study, recombinant vacuole that could target the acute myeloid leukaemia cell line was constructed. The vacuoles derived from genetic engineered yeast were decorated with targeting peptide that has specific affinity with TLR2 on AML cell membrane. The anti-cancer efficacy of AML targeting vacuoles carriers with encapsulated daunorubicin was shown to be higher than normal vacuole carriers and the crude daunorubicin. The results confirmed that target selective chemotherapy using the vacuole drug delivery system is effective and offers potential for cancer therapy.","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"90 1","pages":"147 - 157"},"PeriodicalIF":5.8,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80396272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Protective effect and mechanism of low P50 haemoglobin oxygen carrier on isolated rat heart 低P50血红蛋白氧载体对离体大鼠心脏的保护作用及机制
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-05-12 DOI: 10.1080/21691401.2021.2017947
Wentao Zhou, Shen Li, Shasha Hao, Honghui Zhang, Tao Li, Wanjing Li, Jiaxin Liu, Hong Wang, Chengmin Yang
{"title":"Protective effect and mechanism of low P50 haemoglobin oxygen carrier on isolated rat heart","authors":"Wentao Zhou, Shen Li, Shasha Hao, Honghui Zhang, Tao Li, Wanjing Li, Jiaxin Liu, Hong Wang, Chengmin Yang","doi":"10.1080/21691401.2021.2017947","DOIUrl":"https://doi.org/10.1080/21691401.2021.2017947","url":null,"abstract":"Abstract The protection of the isolated heart is very important in heart transplantation surgery, meanwhile, the ischaemia/reperfusion (I/R) of the isolated heart is the main cause of its damage. A timely supply of oxygen can significantly improve the prevention of myocardial ischaemia, however, the cardioprotective solution does not have an oxygen supply function. Haemoglobin Based on Oxygen Carriers (HBOCs) is a kind of nano-oxygen drug, which can effectively and timely supply oxygen to hypoxic organs and tissues. However, the oxygen-carrying and releasing capacity (P50) is different with different HBOCs. The aim of our study was to investigate whether STS (a kind of cardioprotective solution, St Thomas Solution) +different P50 HBOCs provide superior myocardial protection and decrease myocardial injury compared to only STS in rats Langendorff isolated heart perfusion model. The results showed that STS + HBOCs can improve cardiac function at 37 °C for 35 min and 120 min, and reduce myocardial infarctions, pathological changes, and apoptosis of cardiomyocytes, and the STS + low P50 HBOCs is more effective than the other two higher P50 HBOCs. We further demonstrated the outstanding protective effect of STS + low P50 HBOCs on cardiac function, reducing myocardial infarctions and apoptosis of cardiomyocytes in rat Langendorff isolated heart perfusion model.","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"16 1","pages":"121 - 129"},"PeriodicalIF":5.8,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91133485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system 超声敏感的crgd修饰脂质体作为一种新型给药系统
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-05-11 DOI: 10.1080/21691401.2022.2074439
Nour Alsawaftah, Vinod Paul, Doua Kosaji, Leen Khabbaz, Nahid S Awad, G. Husseini
{"title":"Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system","authors":"Nour Alsawaftah, Vinod Paul, Doua Kosaji, Leen Khabbaz, Nahid S Awad, G. Husseini","doi":"10.1080/21691401.2022.2074439","DOIUrl":"https://doi.org/10.1080/21691401.2022.2074439","url":null,"abstract":"Abstract Targeted liposomes enable the delivery of encapsulated chemotherapeutics to tumours by targeting specific receptors overexpressed on the surfaces of cancer cells; this helps in reducing the systemic side effects associated with the cytotoxic agents. Upon reaching the targeted site, these liposomes can be triggered to release their payloads using internal or external triggers. In this study, we investigate the use of low-frequency ultrasound as an external modality to trigger the release of a model drug (calcein) from non-targeted and targeted pegylated liposomes modified with cyclic arginine–glycine–aspartate (cRGD). Liposomes were exposed to sonication at 20-kHz using three different power densities (6.2, 9, and 10 mW/cm2). Our results showed that increasing the power density increased calcein release from the sonicated liposomes. Moreover, cRGD conjugation to the surface of the liposomes rendered cRGD-liposomes more susceptible to ultrasound compared to the non-targeted liposomes. cRGD conjugation was also found to increase cellular uptake of calcein by human colorectal carcinoma (HCT116) cells which were further enhanced following sonicating the cells with low-frequency ultrasound (LFUS).","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"22 1","pages":"111 - 120"},"PeriodicalIF":5.8,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87264353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Statement of Retraction 撤回声明
IF 5.8 3区 生物学
Artificial Cells, Nanomedicine, and Biotechnology Pub Date : 2022-04-26 DOI: 10.1080/21691401.2022.2054522
{"title":"Statement of Retraction","authors":"","doi":"10.1080/21691401.2022.2054522","DOIUrl":"https://doi.org/10.1080/21691401.2022.2054522","url":null,"abstract":"","PeriodicalId":8736,"journal":{"name":"Artificial Cells, Nanomedicine, and Biotechnology","volume":"13 1","pages":"85 - 85"},"PeriodicalIF":5.8,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73838607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信